Table 1. Clinical and Histopathological Characteristics of our human samples series.
| Group | Glioma Group | Metastasis Group | Control Group | Meningioma Group | Meningioma Control Group | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | (n = 16) | (n = 14) | (n = 11) | (n = 8) | (n = 5) | |||||
| No. | % | No. | % | No. | % | No. | % | No. | % | |
| Clinical findings | ||||||||||
| Mean age at diagnosis, years | 57.7 | — | 57.2 | — | 40.1 | — | 61.4 | — | 72.6 | — |
| Range | 26.2–77.4 | — | 39.8–74.4 | — | 23.9–61.9 | — | 53.2–72.4 | — | 58.6–92.3 | — |
| Gender | ||||||||||
| Male | 11 | 69 | 6 | 43 | 5 | 45 | 2 | 25 | 1 | 33 |
| Female | 5 | 31 | 8 | 57 | 6 | 55 | 6 | 75 | 2 | 67 |
| Previous treatment on Central Nervous system (Surgery and/or Radiotherapy and/or Chemotherapy) | 2 | 13 | 0 | 0 | 0 | 0 | 2 | 25 | 0 | 0 |
| Two-photon Multimodal Imaging | ||||||||||
| Yes | 4 | 25 | 3 | 21 | 3 | 27 | 3 | 38 | 0 | 0 |
| No | 12 | 75 | 11 | 79 | 8 | 63 | 5 | 62 | 5 | 100 |
| Histopathological Findings | ||||||||||
| Necrosis | ||||||||||
| Yes | 12 | 75 | 12 | 86 | 0 | 0 | 2 | 25 | 0 | 0 |
| No | 4 | 25 | 2 | 14 | 11 | 100 | 6 | 75 | 5 | 100 |
| Angiogenesis | ||||||||||
| Yes | 13 | 81 | 1 | 7 | 0 | 0 | 1 | 13 | 0 | 0 |
| No | 3 | 19 | 13 | 93 | 11 | 100 | 7 | 87 | 5 | 100 |
| Mean Proliferation rate (%) | 21 | —* | — | 5 | — | |||||
| Range | 10–40 | — | — | 1–12 | — | |||||
*Only one sample had a calculated proliferation rate.